King Faisal Specialist Hospital, Riyadh – United Arab Emirates
About Dr. Mohammed Alotaibi, MD, MBA
Dr. Mohammed Alotaibi, MD, MBA is a senior Consultant Uro-Oncologist and Professor of Surgery in Riyadh, Saudi Arabia, with over two decades of experience in robotic urological oncology. A leading uro-oncologist in Riyadh, Saudi Arabia, he is a lead or co-author of landmark Saudi research on robotic partial nephrectomy, RARP outcomes in low-volume regions, and the epidemiology of chromophobe renal cell carcinoma.Senior Consultant Uro-Oncologist with 20+ years of clinical experiencePatient recommendation rating 4.5/5 across 91+ reviewsLead or co-author on landmark Saudi research in robotic uro-oncology (RPN, RARP)Professor of Surgery with active academic and research leadershipCo-author on Saudi clinical management guidelines for prostate and renal cancerQualifications & Credentials
Medical Degrees
- MBBS / MD (Doctor of Medicine)
- Urology Residency — Saudi Board / International Equivalent
- Fellowship in Urological Oncology
- MBA — Healthcare Management
Fellowships & Special Training
- Advanced Training in Robotic Urological Oncology
- International Fellowship — Uro-Oncology
Certifications & Accreditations
- FRCSC / Equivalent International Board Certification
- Saudi Commission for Health Specialties Registration
- Saudi Urological Association — Member
- American Urological Association — Member
Areas of Expertise
Major Conditions Treated
- Prostate Cancer
- Kidney Cancer (Renal Cell Carcinoma, including Chromophobe variant)
- Bladder Cancer (Muscle-Invasive & Non-Muscle-Invasive)
- Testicular Cancer
- Upper-Tract Urothelial Carcinoma
- Renal Angiomyolipoma & Tuberous Sclerosis Complex
- Retroperitoneal Tumours
- Benign Prostatic Hyperplasia (BPH)
Sub-specialties
- Robotic Uro-Oncology: Robot-assisted radical prostatectomy, partial nephrectomy, and radical cystectomy — a leading uro-oncology specialist in Riyadh, Saudi Arabia.
- Complex Kidney Cancer Surgery: Nephron-sparing and radical surgery for renal cell carcinoma and complex renal masses.
- Bladder Cancer Management: Radical cystectomy with urinary diversion and trimodal bladder preservation therapy.
Advanced Procedures & Treatments
- Robot-Assisted Radical Prostatectomy (RARP)
- Robotic Partial Nephrectomy (RPN)
- Radical Cystectomy with Urinary Diversion
- Laparoscopic & Open Nephroureterectomy
- Retroperitoneal Lymph Node Dissection (RPLND)
- Robotic Transmesocolonic Pyelolithotomy
Professional Experience
Current Affiliation
- Senior Consultant Uro-Oncologist — King Faisal Specialist Hospital & Research Centre (KFSHRC), Riyadh, Saudi Arabia (Present)
Past Affiliations
- Information not publicly available.
Academic & Research Roles
- Professor of Surgery — Regional academic medical university
- Co-author — Saudi Oncology Society & SUA Clinical Management Guidelines (Prostate, RCC)
- Active contributor to uro-oncology research programme
Key Achievements
- 20+ years of clinical experience in uro-oncology
- Patient recommendation rating 4.5/5 across 91+ reviews
- Lead or co-author on landmark Saudi uro-oncology research
- Extensive academic leadership in urological training
Awards & Recognitions
National & International Awards
- Information not publicly available for named awards; recognised as Professor of Surgery.
Professional Memberships
- Saudi Urological Association
- American Urological Association
- European Association of Urology
- Arab Association of Urology
Research & Publications
Published Papers (Selected)
- Al Otaibi MF, Alkhudair WK, et al. Operative outcomes of robotic partial nephrectomy: A report of the first 101 cases from a single center in Saudi Arabia.
- Al Otaibi MF et al. Robot-Assisted Radical Prostatectomy in Low-Volume Regions: Should It Be Abandoned or Adopted? A Multi-Institutional Outcome Study.
- Seyam R, Bissada N, Kattan S, Alotaibi M, Alkhudair W. The impact of renal angiomyolipoma on estimated glomerular filtration rate in patients with tuberous sclerosis complex.
- Abouelkhair A, Seyam R, et al. (Alotaibi MF co-author). An unexpectedly high prevalence of the chromophobe histopathology subtype in renal carcinoma specimens. 2022.
- Alkhateeb S, Abusamra A, Rabah DM, Alotaibi MF et al. Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for prostate cancer. 2017.
Ongoing Research & Clinical Interests
- Robotic uro-oncological surgery
- Renal cell carcinoma subtype epidemiology
- Bladder cancer management pathways
- Clinical guidelines for urological cancers in Saudi Arabia
Estimated Treatment Costs
| Procedure / Consultation | Estimated Cost (INR) | Estimated Cost (USD) |
|---|---|---|
| Uro-Oncology Consultation | ₹2,000 – ₹4,000 | $24 – $48 |
| Robotic Radical Prostatectomy | ₹3,50,000 – ₹8,00,000 | $4,200 – $9,600 |
| Radical / Partial Nephrectomy (Robotic) | ₹3,00,000 – ₹7,50,000 | $3,600 – $9,000 |
| Radical Cystectomy with Urinary Diversion | ₹4,50,000 – ₹9,00,000 | $5,400 – $10,800 |
| Retroperitoneal Lymph Node Dissection (RPLND) | ₹3,00,000 – ₹6,00,000 | $3,600 – $7,200 |
| Penile / Testicular Cancer Surgery | ₹1,50,000 – ₹4,50,000 | $1,800 – $5,400 |
*Indicative estimates only. Actual costs subject to hospital pricing, case complexity, and insurance. Contact Cancer Rounds for a personalised quote.
Frequently Asked Questions
1. What advanced technologies does Dr. Mohammed Alotaibi, MD, MBA use in Adult Urology (Uro-Oncology) treatment?
Dr. Mohammed Alotaibi performs advanced robotic uro-oncology including robot-assisted radical prostatectomy, robotic partial nephrectomy, radical cystectomy with urinary diversion, retroperitoneal lymph node dissection, and nephron-sparing renal surgery. Virtual consultations and remote second opinions are available to international patients.
2. What conditions does Dr. Mohammed Alotaibi, MD, MBA specialize in treating?
Dr. Mohammed Alotaibi specialises in prostate cancer, kidney cancer (including chromophobe RCC), bladder cancer, testicular cancer, upper-tract urothelial carcinoma, renal angiomyolipoma, retroperitoneal tumours, and BPH in Riyadh, Saudi Arabia.
3. How do I book an appointment with Dr. Mohammed Alotaibi, MD, MBA?
Appointments with Dr. Mohammed Alotaibi, MD, MBA can be booked directly through the Cancer Rounds website or by contacting their international patient department for priority scheduling.
4. Can international patients receive treatment from Dr. Mohammed Alotaibi, MD, MBA?
Yes. Cancer Rounds provides full assistance for international patients seeking treatment from Dr. Mohammed Alotaibi, MD, MBA, including medical visa invitation letters, airport transfers, and local accommodation coordination.
5. What support is available for international patients?
International patients benefit from a dedicated concierge service provided by Cancer Rounds, including language interpretation, financial counseling, and pre-travel virtual consultations to review medical records before arrival.
6. Does Dr. Mohammed Alotaibi, MD, MBA offer second opinions for adult urology (uro-oncology) cases?
Yes. Second opinion consultations can be arranged via Cancer Rounds for patients who wish to review their diagnosis or treatment plan with an expert uro-oncology specialist in Riyadh, Saudi Arabia.
